HEALTH TOPICS 
In brief: Schizophrenia and the metabolic syndrome
In Brief
Schizophrenia and the metabolic syndrome
Results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study show that people with schizophrenia, especially women, are exceptionally vulnerable to the metabolic syndrome.
This set of health risks includes at least three of the following:
To continue reading this article, you must login.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise